Actavis Labs Fl Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?
ACTAVIS LABS FL INC has seventy approved drugs.
There are six tentative approvals on ACTAVIS LABS FL INC drugs.
Drugs and US Patents for Actavis Labs Fl Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl Inc | POTASSIUM CHLORIDE | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 077419-001 | Jun 2, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 206049-001 | May 17, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-004 | Apr 10, 2003 | AB4 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | FENTANYL CITRATE | fentanyl citrate | TABLET;SUBLINGUAL | 207338-002 | Nov 17, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl Inc | PALIPERIDONE | paliperidone | TABLET, EXTENDED RELEASE;ORAL | 202645-003 | Aug 3, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | LACOSAMIDE | lacosamide | TABLET;ORAL | 204855-003 | Jan 5, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl Inc | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 076996-001 | Apr 19, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.